is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CPhI Japan Connect is a virtual platform that allows professionals from around the world to experience CPhI Japan, no matter their location.
Log in and search for companies you’d be interested in working with, by product, sector or company name, connect with them to chat, and arrange video meetings online.
This report highlights trends in Japan’s pharma market, notably how costly, long-listed products will be replaced due to generic and biosimilar industries continuing to grow in volume and market share. It also discusses increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.
Our 2021 Pharma Outlook report has been published in collaboration with some of Pharma’s biggest names to provide key insights that will help you navigate the next 12 months and grow your business.
2020 has been one of the most turbulent years in recent history, casting a shroud of uncertainty over the pharma industry’s future.
Pharma’s response to the COVID-19 pandemic, in terms of vaccine development and treatment distribution, has grabbed many recent headlines, but the major challenges facing the pharma industry are by no means exclusively Coronavirus related.
In interviews with some of the industry’s experts, the 2021 Pharma Outlook report identifies major and emerging trends that will be prominent in 2021.